<DOC>
	<DOCNO>NCT03068754</DOCNO>
	<brief_summary>This multicenter , multiple dose study examine effect H.P . Acthar® ( Acthar ) functional decline adult subject amyotrophic lateral sclerosis ( ALS ) .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety H.P . Acthar® Gel Treatment Subjects With Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>This multicenter , multiple dose study examine effect Acthar functional decline adult subject amyotrophic lateral sclerosis ( ALS ) . Approximately 195 subject enrol . Following screening period 28 day , subject ALS symptom onset ( define first muscle weakness dysarthria ) ≤ 2 year prior Screening Visit randomize 2:1 basis receive subcutaneous ( SC ) Acthar 0.2 mL ( 16 Units [ U ] ) daily ( QD ) SC match placebo 0.2 mL QD 36 week , follow 3 week taper .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>1 . Diagnosis clinically definite ALS , clinically probablelaboratory support ALS , clinically probable ALS base revise El Escorial criterion . 2 . ALS symptom onset ≤ 2 year prior Screening Visit . 3 . On riluzole 50 mg twice day ≥ 4 week prior Screening Visit . 4 . Forced vital capacity ( FVC ) ≥ 60 % Screening Visit . 5 . Systolic blood pressure ≤ 140 mm Hg mean diastolic blood pressure ≤ 90 mm Hg Screening Baseline Visits . 1 . History use adrenocorticotropic hormone ( ACTH ) preparation treatment ALS . 2 . Any medical condition know association motor neuron dysfunction ( ALS ) might confound obscure diagnosis ALS . 3 . Requires nocturnal continuous positive airway pressure bilevel positive airway pressure . 4 . Tracheostomy , diaphragm pacing , ongoing need assist ventilation type Screening Visit . 5 . Known contraindication ( ) Acthar . 6 . History chronic active hepatitis include active chronic hepatitis B , acute chronic hepatitis C. 7 . History tuberculosis ( TB ) infection , signs/symptoms TB , close contact individual active TB infection . 8 . Clinically significant infection require intravenous administration antibiotic hospitalization 4 week prior Screening Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ALS</keyword>
</DOC>